Ameriprise Financial Inc Albireo Pharma, Inc. Transaction History

Ameriprise Financial Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$28.9 - $36.87 $386,132 - $492,620	-13,361 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$32.03 - $42.85 $573,112 - $766,715	-17,893 Reduced 57.25%	13,361 $471,000
Q4 2020 Feb 12, 2021	BUY	$31.56 - $42.16 $986,376 - $1.32 Million	31,254 New	31,254 $1.17 Million

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.